In 2018, a genome-wide association study for major depressiv…

In 2018, a genome-wide association study for major depressive disorder (MDD) was published in the journal Nature Communications. The first Manhattan plot below is from that publication. In this study, genome-wide significant SNPs had a P  7.3, and the cutoff for suggestive SNPs was P=10−6 [-Log10(6)].   1) How many independent loci are associated with MDD at a genome-wide significance level in the 2018 GWAS? [2] 2) If the only difference between these two studies is sample size, which GWAS has the biggest sample size? [2019] 3) If the only difference between these two studies is sample size, do the genome-wide significant variants identified in the 2018 study have a bigger or smaller effect size than most of the genome-wide significant variants identified in the 2019 study? [bigger]